Please assess the completion status of the following clinical trial:

Trial Title: Titrated Versus High and Low Dose Nebulized Morphine to Reduce Pain in Emergency Settings

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* patients older than 8 years and less than 50 years~* patients who consult emergency department for sever pain after an immediately trauma~Exclusion Criteria:~* Glasgow coma scale \<14~* inability to cooperate~* hypotension with systolic blood pressure\< 90mmhg~* bradypnea\<12cpm~* SAO2\<90%~* polytrauma~* nasal trauma~* rhinitis~* nasal obstruction~* allergy to opioids

- Gender: ALL
- Minimum Age: 8 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- IV titrated morphine (Type: PLACEBO_COMPARATOR): patient will receive 2 mg morphine each 5 min, associated to continuous nebulisation of saline serum (placebo).~Morphine administration is stopped when VAS becomes under 50% and treatment failure is defined as VAS \> 50%, 30 minutes after the beginning of the protocol.
- Low dose nebulised morphine (Type: EXPERIMENTAL): patient will receive 10 mg of morphine prepared with 4 ml saline serum (SS) and nebulised with 6 l/min flow during 10 minutes.~Nebulisation will be repeated 3 times, in addition, patients receive 2 ml IV SS every 5 minutes as placebo
- High dose nebulised morphine (Type: EXPERIMENTAL): patient will receive 20 mg of morphine prepared with 3 ml saline serum (SS) and nebulised with 6 l/min flow during 10 minutes.~Nebulisation will be repeated 3 times, in addition, patients receive 2 ml IV SS every 5 minutes as placebo.

Based on this trial design, predict the completion outcome and termination type (if applicable).